Statute Details
- Title: Advance Medical Directive Act 1996
- Act Code: AMDA1996
- Long Title (purpose): Provides for, and gives legal effect to, advance directives to medical practitioners against artificial prolongation of the dying process, and for connected matters.
- Type: Act of Parliament
- Commencement: 1 July 1997 (as indicated in the extract)
- Current status/version: Current version as at 26 Mar 2026 (with key amendments reflected in the 2020 Revised Edition and later amendments)
- Key amendments noted in extract: Amended by Act 21 of 2008; 2020 Revised Edition (in operation 31 Dec 2021); amended by Act 11 of 2023 with changes effective 1 May 2023 (notably to definitions/administration)
- Core mechanism: Legal effect for advance medical directives (AMDs) in specified end-of-life circumstances
- Selected key sections (from metadata/extract): s 3 (power to make directive); s 4 (duty of witness); s 5 (registration); s 6 (confidential registry); s 7 (revocation); s 8 (panel of specialists); s 9 (certification of terminal illness); s 10 (duty of medical practitioner); s 11 (palliative care unaffected); s 13 (other rights unaffected); s 14–16 (offences); s 17 (natural death only; no euthanasia/abetment); s 19 (good faith protection); s 21 (composition of offences); s 22 (regulations)
What Is This Legislation About?
The Advance Medical Directive Act 1996 (“AMDA”) is Singapore’s statutory framework for advance medical directives. In plain terms, it allows a competent adult to record, in advance, what medical treatment they do not want if they later suffer from a terminal illness and death is imminent. The Act is designed to prevent “artificial prolongation of the dying process” by giving legal effect to those prior wishes.
The legislation does not create a general right to refuse all treatment in all circumstances. Instead, it focuses on a specific clinical scenario: when a patient is terminally ill and extraordinary life-sustaining treatment would only postpone death. In that setting, the directive can operate to guide medical decisions—subject to procedural safeguards and statutory limits.
AMDA also addresses practical and ethical concerns. It establishes a confidential registry for directives and revocations, sets out formal requirements for witnessing and registration, and creates offences for fraud, forgery, coercion, and improper use of directives (including as a condition for insurance or medical care). It further clarifies that palliative care remains permissible and that the Act does not authorise euthanasia or abetment of suicide.
What Are the Key Provisions?
1. Who may make a directive and what it covers (s 3 and definitions in s 2). Under s 3(1), a person who is not mentally disordered and has attained 21 years of age may make an advance medical directive in the prescribed form. The directive expresses the person’s desire not to be subjected to “extraordinary life-sustaining treatment” if they are suffering from a “terminal illness”. The Act defines “terminal illness” as an incurable condition where, within reasonable medical judgment, death would be imminent regardless of extraordinary life-sustaining treatment, and such treatment would only serve to postpone the moment of death. “Extraordinary life-sustaining treatment” is defined as medical procedures or measures that only prolong the dying process when death is imminent, excluding palliative care.
2. Formal validity: witnessing requirements and anti-conflict safeguards (s 3(2)–(3) and s 4). A directive must be witnessed by two witnesses present at the same time. One witness must be the patient’s family medical practitioner or another practitioner chosen by the patient; the other must be at least 21 years old. The Act imposes eligibility restrictions on witnesses to reduce conflicts of interest: a witness must not be a beneficiary under the patient’s will or insurance policy, must not have interests under instruments where the patient is donor/settlor/grantor, must not be entitled to interests in the patient’s estate on intestacy, must not be entitled to interests in Central Provident Fund or other provident funds on the patient’s death, and must not have registered an objection under the relevant objection provisions (as reflected in the extract’s reference to s 10(1)).
Additionally, s 4 imposes a duty of witness on a witness who is a medical practitioner. Before witnessing execution, the medical witness must take reasonable steps to ensure the patient: (a) is not mentally disordered; (b) has attained 21; (c) makes the directive voluntarily and without inducement or compulsion; and (d) has been informed of the nature and consequences of making the directive. For practitioners, this is a key compliance point: the Act effectively requires a contemporaneous “process” of informed and voluntary decision-making at the time of execution.
3. Registration and legal effect (s 5 and s 6). A directive made in accordance with s 3 must be registered with the Registrar (s 5(1)). Upon receipt, the Registrar issues an acknowledgment in the prescribed form. Critically, s 5(3) provides that a person must not act on a directive if it has not been registered in accordance with the Act. This means that, in practice, the directive’s operational force depends on registration—an important point for both patients and medical providers.
Section 6 requires the Director-General to establish and maintain a confidential register comprising: (a) all registered directives; (b) all revocations; and (c) all objections by medical practitioners registered under the objection provisions. Confidentiality is strongly protected: the register must not be disclosed except to the directive-maker or authorised persons, the Registrar and appointed administrators, and the medical practitioner responsible for treatment only if a certificate in respect of that person has been forwarded to the Registrar under s 9(1). The Act also creates an offence for wilfully destroying, mutilating, or making unauthorised alterations to the register, with penalties including fines and imprisonment.
4. Revocation and keeping directives current (s 7). The Act allows a patient to revoke a directive in the presence of at least one witness, in writing, orally, or in any other way the patient can communicate. As far as practicable, revocation must be registered with the Registrar. For legal practice, the revocation mechanism is central: it ensures that directives do not become stale or inconsistent with the patient’s current wishes. Practitioners should also note that the Act contains offences relating to concealing revocation (s 14), reinforcing the importance of accurate records.
5. Clinical trigger: certification of terminal illness and medical practitioner duties (s 8–10). The Act contemplates a structured clinical assessment. Section 8 requires the Minister to appoint a panel of at least 20 specialists, each with at least 10 years’ postgraduate medical qualifications (as reflected in the metadata). Section 9 provides for certification of terminal illness. While the extract truncates the remainder, the overall statutory design is clear: before a directive can be acted upon, the patient’s condition must be certified as meeting the statutory definition of terminal illness. This is a safeguard against overreach and ensures that directives are applied only when the legal threshold is met.
Section 10 imposes a duty on the medical practitioner responsible for the treatment of the person. In practical terms, once the statutory conditions are satisfied and the directive is relevant, the medical practitioner must comply with the directive’s effect as provided by the Act. The Act also contains provisions ensuring that palliative care is not affected (s 11) and that patient rights to make informed decisions on treatment are not undermined (s 12), which helps reconcile advance directives with ongoing consent principles.
6. Limits, protections, and offences (ss 11–20). The Act explicitly states that it does not affect palliative care (s 11). It also clarifies that the patient’s rights to make informed decisions on treatment are not affected (s 12) and that the Act does not affect other rights (s 13). These provisions are important for practitioners advising hospitals and clinicians: the directive is not a blanket authorisation to withhold comfort measures.
AMDA contains strong anti-abuse provisions. Section 14 creates penalties for obtaining a directive by fraud, forging a directive, or concealing revocation. Section 15 criminalises the offence of enquiring whether a directive has been made. Section 16 prohibits requiring a directive as a condition for insurance or medical care. These provisions address discrimination and coercion risks, and they protect the autonomy of patients by preventing third parties from using directives as leverage.
Section 17 is a moral and legal boundary: the Act permits only natural death and does not permit euthanasia or abetment of suicide. This is a critical interpretive anchor. It signals that the Act is about refusing extraordinary life-sustaining treatment in a terminal context, not about actively causing death.
Section 19 provides protection for medical practitioners and other persons acting in good faith and without negligence. This is a practical shield for clinicians who comply with the statutory process. Section 20 addresses certain aspects of causation of death, which is relevant to liability analysis in end-of-life cases. Finally, s 21 allows the Director-General or an authorised person to compound offences under the Act, offering an enforcement mechanism short of prosecution.
7. Regulations (s 22). The Minister may make regulations to prescribe anything required by the Act. This typically includes procedural details such as prescribed forms, administrative steps, and operational requirements for the registry and certification processes.
How Is This Legislation Structured?
The AMDA is structured around a logical workflow: (1) enabling individuals to make advance directives (ss 3–4); (2) requiring registration and establishing a confidential registry (ss 5–6); (3) allowing revocation (s 7); (4) creating specialist and certification mechanisms to confirm terminal illness (ss 8–9); (5) imposing duties on medical practitioners when the directive is relevant (s 10); and (6) clarifying the relationship between directives, palliative care, and other patient rights (ss 11–13). The latter part of the Act focuses on integrity and enforcement: offences for fraud/forgery/coercion and improper use (ss 14–16), substantive limits on what the Act authorises (s 17), and legal protections for good-faith actors (ss 19–20), followed by composition of offences and regulations (ss 21–22).
Who Does This Legislation Apply To?
The Act applies primarily to (a) patients who are not mentally disordered, have attained 21 years of age, and make or desire to make a directive; and (b) medical practitioners registered under the Medical Registration Act 1997 who are responsible for treatment of such patients in relevant circumstances. It also applies to witnesses, the Registrar and registry administrators, and specialists involved in certification processes.
In addition, the Act reaches third parties through its offences: it prohibits improper inquiries about whether a directive exists and prohibits requiring directives as conditions for insurance or medical care. It also addresses conduct affecting the registry itself and conduct involving fraud, forgery, or concealment of revocation.
Why Is This Legislation Important?
AMDA is significant because it provides legal effect to end-of-life wishes while embedding procedural safeguards. For practitioners, the Act is not merely ethical guidance; it is a statutory compliance regime. The requirement that directives be in the prescribed form, witnessed under strict conditions, and registered before they can be acted upon means that legal validity and operational enforceability depend on process.
From a risk-management perspective, the Act balances patient autonomy with clinical and legal certainty. The certification and specialist panel framework helps ensure that directives are applied only when the statutory threshold of terminal illness is met. Meanwhile, good-faith protection for medical practitioners and causation-related provisions reduce uncertainty for clinicians who comply with the law.
Finally, the offences and confidentiality rules are central to maintaining public trust. By criminalising fraud, forgery, concealment of revocation, improper enquiries, and coercive use in insurance or medical care, the Act aims to prevent directives from becoming instruments of pressure or discrimination. For lawyers advising healthcare institutions, insurers, or patients, these provisions are essential to structuring compliant policies and documentation practices.
Related Legislation
- Advance Medical Directive Act 1996 (AMDA1996)
- Central Provident Fund Act 1953
- Medical Registration Act 1997
Source Documents
This article provides an overview of the Advance Medical Directive Act 1996 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.